• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

推进前列腺癌检测:PCLDA-SVM 和 PCLDA-KNN 分类器的比较分析,以提高诊断准确性。

Advancing prostate cancer detection: a comparative analysis of PCLDA-SVM and PCLDA-KNN classifiers for enhanced diagnostic accuracy.

机构信息

Electrical and Electronics Engineering, Birla Institute of Technology, Ranchi, Jharkhand, 835215, India.

出版信息

Sci Rep. 2023 Aug 23;13(1):13745. doi: 10.1038/s41598-023-40906-y.

DOI:10.1038/s41598-023-40906-y
PMID:37612436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10447543/
Abstract

This investigation aimed to assess the effectiveness of different classification models in diagnosing prostate cancer using a screening dataset obtained from the National Cancer Institute's Cancer Data Access System. The dataset was first reduced using the PCLDA method, which combines Principal Component Analysis and Linear Discriminant Analysis. Two classifiers, Support Vector Machine (SVM) and k-Nearest Neighbour (KNN), were then applied to compare their performance. The results showed that the PCLDA-SVM model achieved an impressive accuracy rate of 97.99%, with a precision of 0.92, sensitivity of 92.83%, specificity of 97.65%, and F1 score of 0.93. Additionally, it demonstrated a low error rate of 0.016 and a Matthews Correlation Coefficient (MCC) and Kappa coefficient of 0.946. On the other hand, the PCLDA-KNN model also performed well, achieving an accuracy of 97.8%, precision of 0.93, sensitivity of 93.39%, specificity of 97.86%, an F1 score of 0.92, a high MCC and Kappa coefficient of 0.98, and an error rate of 0.006. In conclusion, the PCLDA-SVM method exhibited improved efficacy in diagnosing prostate cancer compared to the PCLDA-KNN model. Both models, however, showed promising results, suggesting the potential of these classifiers in prostate cancer diagnosis.

摘要

本研究旨在评估使用国家癌症研究所癌症数据访问系统获得的筛查数据集,不同分类模型在诊断前列腺癌中的有效性。该数据集首先使用 PCLDA 方法进行了降维,该方法结合了主成分分析和线性判别分析。然后应用了两种分类器,支持向量机(SVM)和 k-最近邻(KNN),以比较它们的性能。结果表明,PCLDA-SVM 模型的准确率达到了惊人的 97.99%,精度为 0.92,灵敏度为 92.83%,特异性为 97.65%,F1 得分为 0.93。此外,它的错误率为 0.016,马修斯相关系数(MCC)和 Kappa 系数分别为 0.946。另一方面,PCLDA-KNN 模型的表现也很好,准确率为 97.8%,精度为 0.93,灵敏度为 93.39%,特异性为 97.86%,F1 得分为 0.92,MCC 和 Kappa 系数均为 0.98,错误率为 0.006。综上所述,与 PCLDA-KNN 模型相比,PCLDA-SVM 方法在诊断前列腺癌方面表现出了更好的效果。然而,这两种模型都取得了有前景的结果,表明这些分类器在前列腺癌诊断中有潜在的应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/557f54c30ae3/41598_2023_40906_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/4ea8e44c1d42/41598_2023_40906_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/9fba91d9a967/41598_2023_40906_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/6c427891758b/41598_2023_40906_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/10b865583dc0/41598_2023_40906_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/e28f1a3f7ce0/41598_2023_40906_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/27b1e7604992/41598_2023_40906_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/a1abbd984865/41598_2023_40906_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/58f52a8af97f/41598_2023_40906_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/474630de2290/41598_2023_40906_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/36649350261c/41598_2023_40906_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/11a6d3dd8cf8/41598_2023_40906_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/2f20fa93ae1d/41598_2023_40906_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/e00dd1bf4ba9/41598_2023_40906_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/123e9a8dbc09/41598_2023_40906_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/b19d5f0df558/41598_2023_40906_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/557f54c30ae3/41598_2023_40906_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/4ea8e44c1d42/41598_2023_40906_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/9fba91d9a967/41598_2023_40906_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/6c427891758b/41598_2023_40906_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/10b865583dc0/41598_2023_40906_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/e28f1a3f7ce0/41598_2023_40906_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/27b1e7604992/41598_2023_40906_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/a1abbd984865/41598_2023_40906_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/58f52a8af97f/41598_2023_40906_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/474630de2290/41598_2023_40906_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/36649350261c/41598_2023_40906_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/11a6d3dd8cf8/41598_2023_40906_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/2f20fa93ae1d/41598_2023_40906_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/e00dd1bf4ba9/41598_2023_40906_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/123e9a8dbc09/41598_2023_40906_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/b19d5f0df558/41598_2023_40906_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bda/10447543/557f54c30ae3/41598_2023_40906_Fig16_HTML.jpg

相似文献

1
Advancing prostate cancer detection: a comparative analysis of PCLDA-SVM and PCLDA-KNN classifiers for enhanced diagnostic accuracy.推进前列腺癌检测:PCLDA-SVM 和 PCLDA-KNN 分类器的比较分析,以提高诊断准确性。
Sci Rep. 2023 Aug 23;13(1):13745. doi: 10.1038/s41598-023-40906-y.
2
From pixels to prognosis: leveraging radiomics and machine learning to predict IDH1 genotype in gliomas.从像素到预后:利用影像组学和机器学习预测胶质瘤中的异柠檬酸脱氢酶1(IDH1)基因型
Neurosurg Rev. 2025 Apr 29;48(1):396. doi: 10.1007/s10143-025-03515-z.
3
Machine learning models for discriminating clinically significant from clinically insignificant prostate cancer using bi-parametric magnetic resonance imaging.使用双参数磁共振成像鉴别临床显著型与临床非显著型前列腺癌的机器学习模型
Diagn Interv Radiol. 2024 Oct 1. doi: 10.4274/dir.2024.242856.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Optimizing machine learning methods for groundwater quality prediction: Case study in District Bagh, Azad Kashmir, Pakistan.优化机器学习方法用于地下水水质预测:以巴基斯坦阿扎德克什米尔地区巴格县为例
Ecotoxicol Environ Saf. 2025 Sep 1;302:118610. doi: 10.1016/j.ecoenv.2025.118610. Epub 2025 Jul 2.
6
Proposal for Using AI to Assess Clinical Data Integrity and Generate Metadata: Algorithm Development and Validation.关于使用人工智能评估临床数据完整性并生成元数据的提案:算法开发与验证
JMIR Med Inform. 2025 Jun 30;13:e60204. doi: 10.2196/60204.
7
The Effectiveness of Supervised Machine Learning in Screening and Diagnosing Voice Disorders: Systematic Review and Meta-analysis.监督机器学习在筛查和诊断嗓音障碍中的有效性:系统评价和荟萃分析。
J Med Internet Res. 2022 Oct 14;24(10):e38472. doi: 10.2196/38472.
8
Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation.用于血尿调查的诊断测试和算法:系统评价与经济评估
Health Technol Assess. 2006 Jun;10(18):iii-iv, xi-259. doi: 10.3310/hta10180.
9
Supervised Machine Learning Models for Predicting Sepsis-Associated Liver Injury in Patients With Sepsis: Development and Validation Study Based on a Multicenter Cohort Study.用于预测脓毒症患者脓毒症相关肝损伤的监督式机器学习模型:基于多中心队列研究的开发与验证研究
J Med Internet Res. 2025 May 26;27:e66733. doi: 10.2196/66733.
10
Leveraging a foundation model zoo for cell similarity search in oncological microscopy across devices.利用基础模型库进行跨设备肿瘤显微镜检查中的细胞相似性搜索。
Front Oncol. 2025 Jun 18;15:1480384. doi: 10.3389/fonc.2025.1480384. eCollection 2025.

引用本文的文献

1
Artificial intelligence driven platform for rapid catalytic performance assessment of nanozymes.用于纳米酶快速催化性能评估的人工智能驱动平台。
Sci Rep. 2025 Apr 17;15(1):13305. doi: 10.1038/s41598-025-96815-9.

本文引用的文献

1
IGWO-IVNet3: DL-Based Automatic Diagnosis of Lung Nodules Using an Improved Gray Wolf Optimization and InceptionNet-V3.IGWO-IVNet3:基于深度学习的改进灰狼优化和 InceptionNet-V3 的肺结节自动诊断
Sensors (Basel). 2022 Dec 7;22(24):9603. doi: 10.3390/s22249603.
2
Adaptive kernel scaling support vector machine with application to a prostate cancer image study.具有自适应核缩放的支持向量机在前列腺癌图像研究中的应用
J Appl Stat. 2021 Jan 8;49(6):1465-1484. doi: 10.1080/02664763.2020.1870669. eCollection 2022.
3
Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials.
基于 PLCO 和 SELECT 试验预测任何及更高等级前列腺癌的未来风险。
BMC Urol. 2022 Mar 26;22(1):45. doi: 10.1186/s12894-022-00986-w.
4
Optimal Deep Learning Enabled Prostate Cancer Detection Using Microarray Gene Expression.基于基因表达微阵列的最优深度学习前列腺癌检测。
J Healthc Eng. 2022 Mar 10;2022:7364704. doi: 10.1155/2022/7364704. eCollection 2022.
5
Prostate Cancer in Older Adults: Risk of Clinically Meaningful Disease, the Role of Screening and Special Considerations.老年男性前列腺癌:临床显著疾病的风险、筛查的作用及特殊考量
Curr Oncol Rep. 2021 Aug 27;23(11):130. doi: 10.1007/s11912-021-01118-7.
6
Digital rectal examination in prostate cancer screening at PSA level 3.0-3.9 ng/ml: long-term results from a randomized trial.PSA 水平在 3.0-3.9ng/ml 时进行前列腺癌筛查的直肠指检:一项随机试验的长期结果。
Scand J Urol. 2021 Oct;55(5):348-353. doi: 10.1080/21681805.2021.1966095. Epub 2021 Aug 19.
7
PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer.PROMISE:一个真实世界的临床基因组数据库,旨在解决前列腺癌中的知识空白。
Prostate Cancer Prostatic Dis. 2022 Sep;25(3):388-396. doi: 10.1038/s41391-021-00433-1. Epub 2021 Aug 6.
8
Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality.用于预测10年前列腺癌死亡率的可解释人工智能模型的开发与验证
Cancers (Basel). 2021 Jun 19;13(12):3064. doi: 10.3390/cancers13123064.
9
PSA-based machine learning model improves prostate cancer risk stratification in a screening population.基于 PSA 的机器学习模型可提高筛查人群中前列腺癌的风险分层。
World J Urol. 2021 Jun;39(6):1897-1902. doi: 10.1007/s00345-020-03392-9. Epub 2020 Aug 3.
10
Global incidence of prostate cancer in developing and developed countries with changing age structures.发展中国家和发达国家中前列腺癌的全球发病率与不断变化的年龄结构。
PLoS One. 2019 Oct 24;14(10):e0221775. doi: 10.1371/journal.pone.0221775. eCollection 2019.